Eyona >> Iindaba >> I-FDA ivuma enye indlela engabizi kwi-EpiPen

I-FDA ivuma enye indlela engabizi kwi-EpiPen

Iindaba

Ulawulo lokutya kunye neziyobisi ( I-FDA Kutshanje kuvunywe okhuphisana ne-EpiPen, i-epinephrine autoinjector ebizwa ngokuba yiSymjepi. UAdamis Pharmaceuticals wenza iSymjepi njengenye yeendleko eziphantsi kwiEpiPen kunye neemveliso ezifanayo. USymjepi unjalo isirinji ekhethwe ngehomoni epinephrine , ezinokukunceda ukuyeka ukusongela ubomi ukusabela okubangelwa yizinambuzane, ukutya, okanye amayeza athile. UAdamis uthi isirinji yayo kulula ukuyisebenzisa kune-Mylan’s EpiPen, isirinji ethwele intwasahlobo eza nesixhobo soqeqesho. Uphononongo lubonise ukuba I-84% yabantu basebenzise ngokungachanekanga i-EpiPen; iimpazamo zibandakanyiwe ukungayibambi ipeni ixesha elide ngokwaneleyo, ukuyibamba kwindawo engafanelekanga emzimbeni, kwaye ungayicinezeli ngokwaneleyo.

Imbali yexabiso le-EpiPen

UMylan Pharmaceuticals, umvelisi we-EpiPen, uqumbise impikiswano ethe xhaxhe xa bonyusa ixabiso lamayeza okusindisa ubomi (epinephrine) ngaphezulu kwama-400%. Ixabiso lesibini se-EpiPens ngo-2007 yayiyi- $ 94 xa i-Mylan Pharmaceuticals yathenga i-EpiPen. Ngo-2016, iindleko zeebini ze-EpiPens zikhule zaya kwi- $ 608. Oku kukhokelele kwingqumbo ebanzi kuluntu jikelele nakwabo bafuna ukuphatha i-EpiPens ngokufanayo, ngakumbi kuba bekuqikelelwa ukuba kubiza i-20 yeedola kuphela ukwenza ipenisi ezimbini zeliyeza libaluleke kangaka.

Ngaxa lithile, U-Mylan ulawulwa ngama-95% Kwimakethi ye-epinephrine auto-injector. IYurophu inokhuphiswano oluninzi kwi-EpiPen, kodwa kude kube ngoku, eUnited States, i-FDA ayikhange ivume naziphi na iimveliso ezikhuphisanayo. Ngenxa yokunyuka kwamaxabiso e-EpiPens, abathengi abaninzi bayayeka ukufumana ii-EpiPens ezintsha okanye basebenzise eziphelelwe lixesha (nangona i-EpiPen kufuneka itshintshwe minyaka le), bebeka ubomi babo emngciphekweni. Impendulo ebukhali inokukhokelela kwi-anaphylaxis esongela ubomi, imeko apho uxinzelelo lwegazi luyehla kunye neendlela zomoya zivale.

Ezinxulumene: Ngaba amayeza aphelelwe lixesha akhuselekile ukuba angawathathwa?

Iindlela ze-EpiPen

Adrenaclick, Omnye umntu okhuphisana naye we-EpiPen, osanda kudibana neekhemesti ze-CVS ezijikeleze iU.S. Inayo ichiza kunye nedosi efanayo ne-EpiPen, kodwa isebenzisa uhlobo olwahlukileyo kancinci lwe-auto-injor.

Olunye uphawu olubizwa ngokuba yi-Auvi-Q lwalusemarikeni kangangexesha elithile kodwa lwakhunjulwa ngo-Okthobha ka-2015 ngenxa yenkxalabo yokuhambisa idosi echanekileyo ye-epinephrine. Ukususela ngoFebruwari 14, 2017, I-Auvi-Q ibuyile kwintengiso ngexabiso lemali eyi- $ 360- kodwa uphawu lunenkqubo eqinisekisa ukuba abantu abane-inshurensi abayi kuba neendleko zokuphuma, kwaye ngekhe babe ngaphandle kweinshurensi abenza ngaphantsi kwe- $ 100,000 ngonyaka. Ukongeza iSymjepi kwintengiso kuya kuzisa inqanaba elitsha lokhuphiswano kuzo zombini i-EpiPen kunye neAdrenaclick.

Ixabisa malini iSymjepi?

Okwangoku, iipakethi ezimbini zeendleko ze-EpiPens malunga ne- $ 630 ngaphandle kweinshurensi. Inguqulelo entsha yohlobo oluqhelekileyo yenziwe (nguMylan), ibuyisela phakathi kwe- $ 225 kunye ne- $ 425. Ixabiso eliphakathi leSymjepi limalunga ne- $ 300 ukuya kwi-500 yeedola. USandoz, umvelisi weSymjepi, osebenzisane noAdamis kwimveliso, unikezela Inkqubo yokonga ezinokunciphisa iindleko zabasebenzisi abafanelekileyo. I-Adamis Pharmaceuticals nayo ifunyenwe Ukuvunywa kwe-FDA for a junior, ithamo labantwana leSymjepi eliza kukhuphisana ngqo nxamnye neMlan's EpiPen Jr.

Bangagcina njani abathengi kwiindlela ze-EpiPen kunye ne-Epipen

Kutshanje uMylan Unikezele ngezaphulelo kwiinkqubo ezimalunga nesithandathu zelizwe zeMedicaid ukuba amazwe angenza kube nzima kwizigulana zeMedicaid ukufumana abakhuphisana nabo be-EpiPen. Oku kuyakwenza ukuba i-EpiPen ifumaneke ngokulula ngelixa iimveliso ezikhuphisanayo ziya kufuna izicelo ezizodwa ngoochwephesha. Amazwe anikezelwayo yayiyiNebraska, Idaho, Maryland, Minnesota, North Carolina, kunye neWisconsin, kodwa akucaci ukuba mangaphi amazwe asamkelayo isipho sikaMylan.

Nangona kunjalo, abathengi ngokungathandabuzekiyo baya kuxhamla kukhuphiswano lweemarike. Ngokubuya kwe-Auvi-Q kwimarike ukusukela ngoFebruwari kwaye iSymjepi iza kungekudala, amaxabiso aya kuqhutyelwa abathengi. Abathengi banokuzifundisa ngezifundo ze- ii-injini zokufaka ezizenzekelayo ezahlukeneyo kwaye sisebenze neenkampani zombini zeinshurensi kunye neenkampani ezixuba amayeza ukufumana amaxabiso afikelelekayo ngonyango olufunekayo.

Njengamaxesha onke, ungawajonga amaxabiso ee-autoinjectors kunye nawo onke amayeza akho kwi-singlecare.com. Nanga amatikiti asimahla e-EpiPen kunye nezinye iindlela: